logo

Oramed Pharmaceuticals Inc. (ORMP)



Trade ORMP now with
  Date
  Headline
6/15/2020 8:31:16 AM Oramed Announces Positive Initial Clinical Trial Results For Treatment Of NASH With Oral Insulin
4/7/2020 7:44:00 AM Oramed Says Patent In Canada Allowed For Oral Delivery Of Proteins
3/19/2020 8:46:53 AM Oramed Announces Positive Feedback From Its Initial End-of-Phase 2 Meeting With FDA
2/27/2020 9:29:26 AM Oramed Pharmaceuticals Prices Public Offering Of 5.25 Mln Shares At $4.00 Per Share
2/26/2020 8:11:31 AM Oramed Reports Positive Results In Final Cohort Of Phase 2b Oral Insulin Trial
1/21/2020 7:26:20 AM Oramed Appoints Jay Skyler To Scientific Advisory Board
9/17/2019 8:43:50 AM Oramed Announces Last Patient Treated In Pivotal Phase IIb Trial Of Oral Insulin ORMD-0801
7/2/2019 8:27:30 AM Oramed Says Xiaoming Gao Is Joining Its Board
5/21/2019 9:00:08 AM Oramed Closes Patient Recruitment Of Phase IIb HbA1c Trial For Oral Insulin Capsule ORMD-0801
3/26/2019 8:41:53 AM Chinese Regulatory Authority Oks IND Application Of Oramed's Oral Insulin Capsules
1/22/2019 8:25:48 AM Oramed Begins Recruitment For Its Phase 1 Pharmacokinetic Study For ORMD-0901
1/9/2019 8:42:36 AM Oramed Receives Milestone Payment Of $3 Mln From Hefei Tianhui Incubator Of Technologies
10/4/2018 8:26:04 AM Oramed Enrolls First Patient In An Exploratory Clinical Study Of Its Oral Insulin Capsule, ORMD-0801